Prion 2016 Oral Abstracts.
出版信息
Prion. 2016;10 Suppl 1(Suppl 1):S22-36. doi: 10.1080/19336896.2016.1163103.
Abstract
摘要
相似文献
1
Prion 2016 Oral Abstracts.朊病毒2016年口头摘要
Prion. 2016;10 Suppl 1(Suppl 1):S22-36. doi: 10.1080/19336896.2016.1163103.
2
Prion and Prion-like Diseases in Humans: Poster Abstracts.人类中的朊病毒及类朊病毒疾病：海报摘要
Prion. 2013 Apr/May;7(sup1):54-80. doi: 10.4161/pri.24865.
3
Prion 2015 oral abstracts.朊病毒2015年口头摘要
Prion. 2015;9 Suppl 1(sup1):S1-S10. doi: 10.1080/19336896.2015.1036655.
4
The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis.小肠而非大肠中的肠道相关淋巴组织在经口感染朊病毒疾病发病机制中起主要作用。
J Virol. 2015 Sep;89(18):9532-47. doi: 10.1128/JVI.01544-15. Epub 2015 Jul 8.
5
Oral Prion Neuroinvasion Occurs Independently of PrP Expression in the Gut Epithelium.口腔朊病毒神经入侵独立于肠道上皮细胞中的 PrP 表达。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01010-18. Print 2018 Oct 1.
6
Oral Ingestion of Synthetically Generated Recombinant Prion Is Sufficient to Cause Prion Disease in Wild-Type Mice.经口摄入人工合成的重组朊病毒足以在野生型小鼠中引发朊病毒疾病。
Pathogens. 2020 Aug 13;9(8):653. doi: 10.3390/pathogens9080653.
7
Prion disease: possible implications for oral health care.朊病毒病：对口腔保健的潜在影响。
J Am Dent Assoc. 2003 Nov;134(11):1486-91. doi: 10.14219/jada.archive.2003.0079.
8
Distinct transmissibility features of TSE sources derived from ruminant prion diseases by the oral route in a transgenic mouse model (TgOvPrP4) overexpressing the ovine prion protein.经口途径传播的源于反刍动物朊病毒病的 TSE 来源在过表达绵羊朊病毒蛋白的转基因小鼠模型（TgOvPrP4）中的不同传播特性。
PLoS One. 2014 May 5;9(5):e96215. doi: 10.1371/journal.pone.0096215. eCollection 2014.
9
Prion 2016 Animal Prion Disease Workshop Abstracts.
Prion. 2016;10 Suppl 1(Suppl 1):S15-21. doi: 10.1080/19336896.2016.1163048.
10
Subclinical prion disease induced by oral inoculation.经口接种诱导的亚临床朊病毒病
J Virol. 2003 Jul;77(14):7991-8. doi: 10.1128/jvi.77.14.7991-7998.2003.
本文引用的文献
1
Protein folding activity of the ribosome (PFAR) -- a target for antiprion compounds.核糖体的蛋白质折叠活性（PFAR）——抗朊病毒化合物的一个靶点。
Viruses. 2014 Oct 23;6(10):3907-24. doi: 10.3390/v6103907.
2
The toll-like receptor agonist imiquimod is active against prions. Toll 样受体激动剂咪喹莫特对朊病毒有活性。
PLoS One. 2013 Aug 16;8(8):e72112. doi: 10.1371/journal.pone.0072112. eCollection 2013.
3
The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition.抗朊病毒化合物 6-氨基菲啶通过直接竞争抑制核糖体的蛋白质折叠活性。
J Biol Chem. 2013 Jun 28;288(26):19081-9. doi: 10.1074/jbc.M113.466748. Epub 2013 May 14.
4
Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding.抗朊病毒药物 6AP 和 GA 对核糖体辅助蛋白折叠作用模式的研究。
Biochimie. 2011 Jun;93(6):1047-54. doi: 10.1016/j.biochi.2011.03.002. Epub 2011 Mar 17.
5
Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.抗朊病毒药物 6-氨基菲啶和胍那苄可降低眼咽型肌营养不良症中 PABPN1 的毒性和聚集。
EMBO Mol Med. 2011 Jan;3(1):35-49. doi: 10.1002/emmm.201000109.
6
Natural and synthetic prion structure from X-ray fiber diffraction.天然和合成朊病毒结构的 X 射线纤维衍射。
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):16990-5. doi: 10.1073/pnas.0909006106. Epub 2009 Sep 28.
7
Role of the ribosome in protein folding.核糖体在蛋白质折叠中的作用。
Biotechnol J. 2008 Aug;3(8):999-1009. doi: 10.1002/biot.200800098.
8
Tools for the study of ribosome-borne protein folding activity.用于研究核糖体携带的蛋白质折叠活性的工具。
Biotechnol J. 2008 Aug;3(8):1033-40. doi: 10.1002/biot.200800134.
9
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.抗高血压药物胍那苄在体内对酵母和哺乳动物朊病毒均有活性。
PLoS One. 2008 Apr 23;3(4):e1981. doi: 10.1371/journal.pone.0001981.
10
Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core.HET-s(218 - 289)朊病毒的淀粉样纤维形成了一个具有三角形疏水核心的β螺线管。
Science. 2008 Mar 14;319(5869):1523-6. doi: 10.1126/science.1151839.
Zotero 插件